Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study

  • Guttorm Raknes,
  • Lars Småbrekke

There are a number of errors in Table 3. The value in column 7 "% points" for the line “LDN x 4+” in the group “All examined medicines” should be -3.3, not 0. Additionally, the p-values in the ninth column “P” are incorrect. Please see the correct Table 3 here.

thumbnail
Download:
Table 3. The number of users of examined medicines among patients with rheumatoid and seropositive arthritis one year before and after the first dispense of LDN.

https://doi.org/10.1371/journal.pone.0223545.t001

There are a number of errors in S2 Table. The p-values in the ninth column “P” are incorrect. Please view the correct S2 Table below.

Supporting information

S2 Table. The number of users of medicines classified as Other DMARDs among patients with rheumatoid and seropositive arthritis one year before and after the first dispense of LDN.

https://doi.org/10.1371/journal.pone.0223545.s001

(PDF)

Reference

  1. 1. Raknes G, Småbrekke L (2019) Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study. PLoS ONE 14(2): e0212460. https://doi.org/10.1371/journal.pone.0212460 pmid:30763385

Citation: Raknes G, Småbrekke L (2019) Correction: Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study. PLoS ONE 14(10): e0223545. https://doi.org/10.1371/journal.pone.0223545

Published: October 1, 2019

Copyright: © 2019 Raknes, Småbrekke. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.